Literature DB >> 29476861

Thimerosal changes protein conformation and increase the rate of fibrillation in physiological conditions: Spectroscopic studies using bovine serum albumin (BSA).

João César N Santos1, Isabella M da Silva1, Taniris C Braga2, Ângelo de Fátima2, Isis M Figueiredo1, Josué Carinhanha Caldas Santos3.   

Abstract

The interaction between bovine serum albumin (BSA) and thimerosal (TM), an organomercury compound widely employed as a preservative in vaccines, was investigated simulating physiological conditions and using different spectroscopic techniques. The results, employing molecular fluorescence showed the interaction occurs by static quenching through electrostatic forces (ΔH < 0 and ΔS > 0), spontaneously (ΔG = -4.40 kJ mol-1) and with a binding constant of 3.24 × 103 M-1. Three-dimensional fluorescence studies indicated that TM causes structural changes in the polypeptide chain of the BSA, confirmed by circular dichroism that showed an increase in α-helix (from 43.9 to 47.8%) content after interaction process. Through synchronized fluorescence and employing bilirubin as a protein site marker, it was confirmed the preferential interaction of TM in the subdomain IB of BSA. The interaction mechanism proposed in this work is based on the reaction of TM with BSA through of free Cys34 residue, forming the adduct BSA-HgEt with the thiosalicylic acid release, which possibly interacts electrostatically with positive side chain amino acids of the modified protein. Finally, it was proven that both TM and EtHgCl accelerate the protein fibrillation kinetics in 42 and 122%, respectively, indicating the toxicity of these compounds in biological systems.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BSA and ethylmercury; Interaction mechanism; Protein fibrillation; Thimerosal

Mesh:

Substances:

Year:  2018        PMID: 29476861     DOI: 10.1016/j.ijbiomac.2018.02.116

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

1.  Sulfhydryl groups as targets of mercury toxicity.

Authors:  Olga P Ajsuvakova; Alexey A Tinkov; Michael Aschner; João B T Rocha; Bernhard Michalke; Margarita G Skalnaya; Anatoly V Skalny; Monica Butnariu; Maryam Dadar; Ioan Sarac; Jan Aaseth; Geir Bjørklund
Journal:  Coord Chem Rev       Date:  2020-05-07       Impact factor: 22.315

2.  Genetic and metabolic signatures of Salmonella enterica subsp. enterica associated with animal sources at the pangenomic scale.

Authors:  Meryl Vila Nova; Kévin Durimel; Kévin La; Arnaud Felten; Philippe Bessières; Michel-Yves Mistou; Mahendra Mariadassou; Nicolas Radomski
Journal:  BMC Genomics       Date:  2019-11-06       Impact factor: 3.969

3.  Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine.

Authors:  Kawaljit Kaur; Jian Xiong; Nishant Sawant; Sanjeev Agarwal; John M Hickey; David A Holland; Tarit K Mukhopadhyay; Joseph R Brady; Neil C Dalvie; Mary Kate Tracey; Kerry R Love; J Christopher Love; David D Weis; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2020-12-03       Impact factor: 3.534

4.  Insights into the interaction mechanism between tiagabine hydrochloride and two serum albumins.

Authors:  Weiling Zhuo; Xilin Peng; Xiang Lin
Journal:  RSC Adv       Date:  2018-07-11       Impact factor: 4.036

5.  Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens.

Authors:  Sanjeev Agarwal; John M Hickey; David McAdams; Jessica A White; Robert Sitrin; Lakshmi Khandke; Stanley Cryz; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2019-10-04       Impact factor: 3.534

6.  Effect of Caffeine and Flavonoids on the Binding of Tigecycline to Human Serum Albumin: A Spectroscopic Study and Molecular Docking.

Authors:  Miroslav Sovrlić; Emina Mrkalić; Ratomir Jelić; Marina Ćendić Serafinović; Stefan Stojanović; Nevena Prodanović; Jovica Tomović
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.